Literature DB >> 3581462

Farmer's lung--a 5-year follow-up of eighty-six patients.

S Mönkäre, T Haahtela.   

Abstract

We studied the clinical course of eighty-six patients with farmer's lung for a period of 5 years. The patients were first evaluated at an acute or sub-acute stage of the disease and 1, 3, 6, 12 and 60 months thereafter. Special attention was paid to the development of lung function and radiological findings with reference to corticosteroid treatment and antigen contact during the follow-up. Many of the patients were severely ill at the acute stage of the disease. Most of the recovery took place during the first month. Significant improvement of lung function happened up to 6 months, thereafter the improvement was insignificant. After 5 years, respiratory symptoms were reported by 65% and minor respiratory dysfunction (lowered diffusing capacity) was observed in about 40% of the farmers. Thirty-two per cent of the patients showed diffuse opacities in chest X-ray. Corticosteroid treatment had no effect on long term prognosis. There was no difference in the recovery of lung function between those who returned to work compared with those who did not. Exacerbations happened in 8% of the patients during the follow-up. We conclude that respiratory symptoms, minor airway dysfunction and mild radiological fibrosis are common findings after 5 years of an acute or sub-acute stage of the farmer's lung. However, in Finland two-thirds of the patients return back to their previous occupation of farming and cattle feeding.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3581462     DOI: 10.1111/j.1365-2222.1987.tb02332.x

Source DB:  PubMed          Journal:  Clin Allergy        ISSN: 0009-9090


  15 in total

1.  Follow up investigation of workers in synthetic fibre plants with humidifier disease and work related asthma.

Authors:  T M Pal; J G de Monchy; J W Groothoff; D Post
Journal:  Occup Environ Med       Date:  1999-06       Impact factor: 4.402

2.  Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis.

Authors:  Evans R Fernández Pérez; Jeffrey J Swigris; Anna V Forssén; Olga Tourin; Joshua J Solomon; Tristan J Huie; Amy L Olson; Kevin K Brown
Journal:  Chest       Date:  2013-11       Impact factor: 9.410

3.  Gammadelta T cells and Th17 cytokines in hypersensitivity pneumonitis and lung fibrosis.

Authors:  Philip L Simonian; Christina L Roark; Willi K Born; Rebecca L O'Brien; Andrew P Fontenot
Journal:  Transl Res       Date:  2009-09-09       Impact factor: 7.012

4.  Health and safety risks in production agriculture.

Authors:  S G Von Essen; S A McCurdy
Journal:  West J Med       Date:  1998-10

Review 5.  Bird fancier's lung: a state-of-the-art review.

Authors:  Andrew L Chan; Maya M Juarez; Kevin O Leslie; Heba A Ismail; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2012-08       Impact factor: 8.667

6.  Farmers lung: a three year survey and comparison of ELISA and CIEP techniques in antibody detection.

Authors:  M Melinn; H McLaughlin
Journal:  Ir J Med Sci       Date:  1989-07       Impact factor: 1.568

7.  Longitudinal course of extrinsic allergic alveolitis in pigeon breeders.

Authors:  S J Bourke; S W Banham; R Carter; P Lynch; G Boyd
Journal:  Thorax       Date:  1989-05       Impact factor: 9.139

8.  Hypersensitivity pneumonitis in a cluster of sawmill workers: a 10-year follow-up of exposure, symptoms, and lung function.

Authors:  Karl Færden; May Brit Lund; Trond Mogens Aaløkken; Wijnand Eduard; Per Søstrand; Sverre Langård; Johny Kongerud
Journal:  Int J Occup Environ Health       Date:  2014 Apr-Jun

Review 9.  Mold and human health: separating the wheat from the chaff.

Authors:  H David Pettigrew; Carlo F Selmi; Suzanne S Teuber; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

10.  Th17-polarized immune response in a murine model of hypersensitivity pneumonitis and lung fibrosis.

Authors:  Philip L Simonian; Christina L Roark; Fabian Wehrmann; Allison K Lanham; Fernando Diaz del Valle; Willi K Born; Rebecca L O'Brien; Andrew P Fontenot
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.